Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/119858
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2024-03-14T12:11:19Z-
dc.date.available2024-03-14T12:11:19Z-
dc.date.issued2020-
dc.identifier.citationFarrugia Bajada, E. (2020). Functional characterisation and pharmacogenetic relevance of a novel gene associated with poor lung function (Master’s dissertation).en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/119858-
dc.descriptionM.Phil.(Melit.)en_GB
dc.description.abstractIntroduction: The single nucleotide polymorphism (SNP) rs6889822 has been reported to be sentinel SNP in a leading genome wide association study (GWAS) which strongly associated the HTR4 gene with the phenotype for altered lung function and COPD. It has also been identified as an expression quantitative trait locus (eQTL) of FBXO38 gene expression in humans and although to date literature supports no direct role for the FBXO38 gene in lung diseases, the eQTL association between rs6889822 and FBXO38 provides a basis for this. Aim: To study the influence of experimentally altered knockdown and overexpression of the FBXO38 gene on downstream pathways, using an in vitro airway cell culture model. Methodology: Knockdown of the FBXO38 gene in H460 airway lung model and HEK-293 experimental model was carried out through transfection of FBXO38 specific siRNA duplexes. An overexpression plasmid vector for delivery of wild type FBXO38 into the H460 lung model and HEK-293 experimental model was designed. Delivery of both the siRNA and recombinant FBXO38 plasmid was carried out by magnetofection. A comparative transcriptome carried out on duplicate samples between normal and altered FBXO38 overexpression and knockdown was obtained through RNA sequencing. The resulting sequencing data was bioinformatically analysed using a differential expressed genes (DEG) and gene set enrichment analysis (GSEA) approaches for patterns of differential gene expression and pathways associated with poor lung function. Results: Following analysis of RNAseq knockdown and overexpression data, 11 significantly differentially expressed genes were isolated through DEG analysis, and 3 significantly activated pathways were identified using GSEA analysis. A combination of bioinformatics and literature review particularly identified three differentially expressed genes, JUN, MAP2 and ITCH to have important airway regulatory roles tied to FBXO38 knockdown. The ubiquitination and proteasome degradation pathway was identified as being significantly activated with respect to FBXO38 knockdown. No differential expression was observed in overexpression samples. Conclusion: The results propose a role for FBXO38 in deregulation of the airway proteasome through its action as an E3 ubiquitin ligase capable of exerting an SCF dependant regulatory effect characteristic of its F-box protein class. In addition to this the genes JUN, MAP2 and ITCH were identified to have important airway regulatory roles tied to FBXO38 knockdown. The combined strengths of these observations propose FBXO38 to be a strong and promising potential candidate for further study in relation to altered lung function and the pathophysiology of chronic airway disease.en_GB
dc.language.isoenen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectSingle nucleotide polymorphismsen_GB
dc.subjectAsthma -- Maltaen_GB
dc.subjectLungs -- Diseases, Obstructive -- Maltaen_GB
dc.subjectGene expressionen_GB
dc.subjectRNAen_GB
dc.subjectGeneticsen_GB
dc.subjectCell linesen_GB
dc.subjectBioinformaticsen_GB
dc.titleFunctional characterisation and pharmacogenetic relevance of a novel gene associated with poor lung functionen_GB
dc.typemasterThesisen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Medicine and Surgery. Department of Clinical Pharmacology and Therapeuticsen_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorFarrugia Bajada, Edwina (2020)-
Appears in Collections:Dissertations - FacM&S - 2020
Dissertations - FacM&SCPT - 2020

Files in This Item:
File Description SizeFormat 
2321MDSCPH500005014782_1.PDF
  Restricted Access
10.77 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.